- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
An American Journal of Managed Care® Symposium: Examining Treatment Advancements in Psoriasis and Psoriatic Arthritis
Related Videos
The Future of Oral Therapy for Psoriasis Management
Zasocitinib’s Potential as an Oral Treatment for Psoriasis
Dr Chesahna Kindred: Diverse Clinical Trials Are a Long-Game to Close the Health Equity Gaps
Dr Chesahna Kindred Addresses Diversity Barriers in Clinical Trials
Dr Chesahna Kindred Discusses the Strengths of Diversity in Psoriasis Clinical Trials
Dr Joseph Zabinski Discusses Challenges in Identifying Patients With GPP
Dr Joseph Zabinski Discusses Using Artificial Intelligence to Identify Patients With GPP
JNJ-2113 Shows Promising Response Rates Compared With Competitor Oral Therapies for Psoriasis
The Importance of Cultural, Social, and Clinical Diversity in Treating Plaque Psoriasis
Dr Mona Shahriari Talks Unique Challenges in Treating Psoriasis in Patients With Skin of Color
Related Content
Icotrokinra Shows Clear Skin in 75% of Adolescents With Plaque Psoriasis in Phase 3 Trial
April 10th 2025Article
New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of once-daily icotrokinra (JNJ-2113) in adolescents with moderate to severe plaque psoriasis.
Read More
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
August 3rd 2021Podcast
August is National Psoriasis Awareness Month, and on this episode of Managed Care Cast, we bring you an excerpt of an interview with a New Jersey dermatologist about the changing concept of psoriasis as more than just a skin disease.
Listen
